Disc Medicine, Inc. (IRON)
USD 63.5
(-2.31%)
USD 63.5
(-2.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of Revenue | 100 Thousand | 300 Thousand | 192 Thousand | 322 Thousand |
| Gross Profit | -100 Thousand | -300 Thousand | -192 Thousand | -322 Thousand |
| Operating Expenses | 91.12 Million | 47.47 Million | 30.93 Million | 34.04 Million |
| Selling, General and Administrative Expenses | 21.86 Million | 14.03 Million | 5.76 Million | 5.87 Million |
| Research and Development Expenses | 69.16 Million | 33.43 Million | 25.17 Million | 28.17 Million |
| Other Expenses | - | 648 Thousand | -724 Thousand | - |
| Cost and Expenses | 91.12 Million | 47.47 Million | 30.93 Million | 34.04 Million |
| Operating Income | -91.12 Million | -47.47 Million | -30.93 Million | -34.04 Million |
| Interest Expense | - | - | 2.15 Million | 6.82 Million |
| Income Tax Expense | 99 Thousand | -737 Thousand | 5.03 Million | 6.82 Million |
| Earnings before Tax | -76.33 Million | -46.82 Million | -35.96 Million | -40.83 Million |
| Net Income | -76.42 Million | -46.09 Million | -41 Million | -47.66 Million |
| Earnings Per Share Basic | -3.43 | -44.34 | -12.80 | -10.52 |
| Earnings Per Share Diluted | -3.42 | -44.34 | -12.80 | -10.52 |
| Weighted Average Shares Outstanding | 22.31 Million | 1.03 Million | 3.2 Million | 4.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.31 Million | 1.03 Million | 3.2 Million | 4.53 Million |
| Gross Margin | - | - | - | - |
| EBIT Margin | - | - | - | - |
| Profit Margin | - | - | - | - |
| EBITDA | -91.02 Million | -46.52 Million | -35.77 Million | -33.68 Million |
| Earnings Before Tax Margin | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 110 Thousand | 26 Thousand | 100 Thousand | 25 Thousand | 25 Thousand | 75 Thousand |
| Gross Profit | -110 Thousand | -26 Thousand | -100 Thousand | -25 Thousand | -25 Thousand | -75 Thousand |
| Operating Expenses | 30.85 Million | 31.46 Million | 91.02 Million | 29.71 Million | 18.95 Million | 17.32 Million |
| Selling, General and Administrative Expenses | 7.36 Million | 7.75 Million | - | 7.14 Million | 4.53 Million | 5.22 Million |
| Research and Development Expenses | 23.48 Million | 23.7 Million | - | 22.56 Million | 14.41 Million | 12.1 Million |
| Other Expenses | -13 Thousand | -1000.00 | - | -10 Thousand | 13 Thousand | -5000.00 |
| Cost and Expenses | 30.85 Million | 31.46 Million | 91.12 Million | 29.71 Million | 18.95 Million | 17.32 Million |
| Operating Income | -30.85 Million | -31.46 Million | -91.12 Million | -29.71 Million | -18.95 Million | -17.32 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 60 Thousand | 5000.00 | 99 Thousand | 32 Thousand | 20 Thousand | 24 Thousand |
| Earnings before Tax | -26.29 Million | -26.94 Million | -76.33 Million | -23.54 Million | -14.1 Million | -15.92 Million |
| Net Income | -26.35 Million | -26.94 Million | -76.42 Million | -23.57 Million | -14.12 Million | -15.94 Million |
| Earnings Per Share Basic | -1.03 | -1.09 | - | -1.00 | -0.58 | -0.74 |
| Earnings Per Share Diluted | -1.03 | -1.09 | - | -1.00 | -0.58 | -0.74 |
| Weighted Average Shares Outstanding | 25.64 Million | 24.8 Million | 22.31 Million | 23.56 Million | 24.31 Million | 21.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.64 Million | 24.8 Million | 22.31 Million | 23.56 Million | 24.31 Million | 21.48 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -30.74 Million | -31.43 Million | - | -29.68 Million | -18.93 Million | -15.8 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
SLTFF
APCXW
LPCUF
FSXLF
7990
VGMIF